Loading…
National Neurotechnology Initiative Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
52pct
4d open
vs 6,490 other HR bills in the 111th — cohort avg 44d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2010 · fourth_quarter · Medical/Disease Research/Clinical Labs
Advocate for HR 1483 and S 586, the National Neurotechnology Initiative Act, all provisions.
Client expense: Not reported · Firm income: Not reported
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Health Issues
Advocate for H.R.1483 and S.586, the National Neurotechnology Initiative Act, all provisions.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Health Issues
Advocate for H.R.1483 and S.586, the National Neurotechnology Initiative Act, all provisions.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Medical/Disease Research/Clinical Labs
Advocate for HR 1483 and S 586, the National Neurotechnology Initiative Act, all provisions.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Health Issues
Advocate for H.R.1483 and S.586, the National Neurotechnology Initiative Act, all provisions.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Medical/Disease Research/Clinical Labs
Advocate for HR 1483 and S 586, the National Neurotechnology Initiative Act, all provisions.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · first_quarter · Health Issues
Advocate for H.R.1483 and S.586, the National Neurotechnology Initiative Act, all provisions.
Client expense: Not reported · Firm income: Not reported
2010 · first_quarter · Medical/Disease Research/Clinical Labs
Advocate for HR 1483 and S 586, the National Neurotechnology Initiative Act, all provisions.
Client expense: Not reported · Firm income: Not reported
2009 · second_quarter · Health Issues
Advocate for H.R.1483 and S.586, the National Neurotechnology Initiative Act, all provisions.
Client expense: Not reported · Firm income: Not reported
2009 · second_quarter · Medical/Disease Research/Clinical Labs
Advocate for HR 1483 and S 586, the National Neurotechnology Initiative Act, all provisions.
Client expense: Not reported · Firm income: Not reported
2009 · fourth_quarter · Medical/Disease Research/Clinical Labs
Advocate for HR 1483 and S 586, the National Neurotechnology Initiative Act, all provisions.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · fourth_quarter · Health Issues
Advocate for H.R.1483 and S.586, the National Neurotechnology Initiative Act, all provisions.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · third_quarter · Health Issues
Advocate for H.R.1483 and S.586, the National Neurotechnology Initiative Act, all provisions.
Client expense: Not reported · Firm income: Not reported
2009 · third_quarter · Medical/Disease Research/Clinical Labs
Advocate for HR 1483 and S 586, the National Neurotechnology Initiative Act, all provisions.
Client expense: Not reported · Firm income: Not reported
2009 · second_quarter · Health Issues
Advocate for H.R.1483 and S.586, the National Neurotechnology Initiative Act, all provisions.
Client expense: Not reported · Firm income: Not reported
2009 · second_quarter · Medical/Disease Research/Clinical Labs
Advocate for HR 1483 and S 586, the National Neurotechnology Initiative Act, all provisions.
Client expense: Not reported · Firm income: Not reported
2009 · first_quarter · Health Issues
Advocate for H.R.1483 and S.586, the National Neurotechnology Initiative Act, all provisions.
Client expense: Not reported · Firm income: Not reported
2009 · first_quarter · Medical/Disease Research/Clinical Labs
Advocate for HR 1483 and S 586, the National Neurotechnology Initiative Act, all provisions.
Client expense: Not reported · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
| Democratic |
| OR |
| Ileana Ros-Lehtinen | Republican | FL |
| James P. McGovern | Democratic | MA |
| Joe Sestak | Democratic | PA |
| Mike Thompson | Democratic | CA |
| Pete Sessions | Republican | TX |
| Steve Cohen | Democratic | TN |
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE